National Health Investors Quarterly Income Statement
NYSE: NHIReal EstateReal Estate Investment TrustsUSD
At close: Oct 9, 4:00 PM ET · Delayed 15 min
National Health Investors revenue and earnings
In the quarter ended Jun 30, 2026, National Health Investors generated $121.3 million in revenue, up 33.8% from the same quarter a year earlier. Net income was $55.7 million (+50.5% year over year), for a net margin of 45.9% versus a median of 36.6% in the prior 5 quarters. Diluted earnings per share came in at $1.15, up from $0.79.
Summary generated from market data by MetaCap's automated system. Methodology
National Health Investors income statement (quarterly)
| Quarter (USD) | Q2 20262026-06-30 | Q1 20262026-03-31 | Q4 20252025-12-31 | Q3 20252025-09-30 | Q2 20252025-06-30 | Q1 20252025-03-31 | Q4 20242024-12-31 | Q3 20242024-09-30 | Q2 20242024-06-30 | Q1 20242024-03-31 | Q4 20232023-12-31 | Q3 20232023-09-30 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | 121.32M | 115.13M | 105.82M | 89.85M | 90.66M | 89.30M | 85.75M | 82.94M | 84.97M | 81.51M | 79.47M | 80.11M |
| Revenue growth (YoY) | +33.81% | +28.93% | +23.40% | +8.32% | +6.70% | +9.55% | +7.92% | +3.54% | +9.11% | -1.06% | +12.45% | +4.99% |
| Operating Expenses | 87.28M | 78.03M | 69.79M | 57.55M | 55.61M | 56.01M | 54.19M | 54.80M | 51.77M | 51.12M | 49.52M | 52.01M |
| Interest Expense | 15.81M | 15.04M | 14.26M | 13.77M | 15.00M | 14.34M | 15.24M | 14.94M | 14.85M | 14.87M | 14.85M | 15.09M |
| Other Income (Expense) | 86.00K | 35.00K | — | — | 0 | 0 | 0 | 0 | — | — | 0 | 202.00K |
| Pretax Income | 56.09M | — | — | — | 35.16M | — | — | — | — | — | — | — |
| Income Tax | 732.00K | — | — | — | 0 | — | — | — | — | — | — | — |
| Net Income | 55.67M | 40.10M | 38.16M | 32.86M | 36.99M | 34.16M | 43.24M | 28.54M | 35.26M | 30.95M | 32.05M | 29.35M |
| Net Income growth (YoY) | +50.52% | +17.38% | -11.75% | +15.14% | +4.91% | +10.40% | +34.94% | -2.75% | -11.37% | -10.26% | +1620.13% | -14.86% |
| EPS (Basic) | 1.15 | 0.83 | 0.80 | 0.69 | 0.79 | 0.75 | 0.96 | 0.66 | 0.81 | 0.71 | 0.74 | 0.68 |
| EPS (Diluted) | 1.15 | 0.82 | 0.80 | 0.69 | 0.79 | 0.74 | 0.96 | 0.65 | 0.81 | 0.71 | 0.74 | 0.68 |
| Shares Outstanding (Basic) | 48.44M | 48.32M | — | 47.43M | 46.69M | 45.72M | — | 43.48M | 43.40M | 43.39M | — | 43.39M |
| Shares Outstanding (Diluted) | 48.50M | 48.55M | — | 47.62M | 46.82M | 45.88M | — | 43.99M | 43.56M | 43.42M | — | 43.39M |
| Net Margin | 45.89% | 34.83% | 36.06% | 36.58% | 40.80% | 38.26% | 50.43% | 34.41% | 41.49% | 37.97% | 40.33% | 36.63% |
This table shows 12 quarterly periods of National Health Investors's income statement, from Q2 2026 back to Q3 2023, across 15 line items including revenue, operating expenses, operating income. Values in USD; B = billions, M = millions. Fiscal periods follow NHI's reporting calendar. What is a income statement?